Explore more publications!
Idaho Sci-Tech Network
Got News to Share?

Idaho Sci-Tech Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 5, 2025

DOXA® Talent Announces Launch of DOXA Labs™ to Upskill Offshore Talent with Applied AI
December 5, 2025

DOXA® Talent Announces Launch of DOXA Labs™ to Upskill Offshore Talent with Applied AI

Indeterminate EIN Presswire
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
December 5, 2025

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Indeterminate GlobeNewswire
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
December 5, 2025

Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO

Indeterminate GlobeNewswire
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 5, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
December 5, 2025

Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing

Indeterminate GlobeNewswire
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 5, 2025

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Grants of Inducement Awards
December 5, 2025

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025
December 5, 2025

Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025

Indeterminate GlobeNewswire
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 5, 2025

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 5, 2025

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Announcement relating to despatch of Rule 15 proposal
December 5, 2025

Announcement relating to despatch of Rule 15 proposal

Indeterminate GlobeNewswire
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
December 5, 2025

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire
MiLi Christmas Limited Edition — Christmas Gift Ideas That Shines Beyond the Holidays
December 5, 2025

MiLi Christmas Limited Edition — Christmas Gift Ideas That Shines Beyond the Holidays

Indeterminate GlobeNewswire
Evalyze Launches AI Investor Matching Engine to Help Startups Fundraise Faster
December 5, 2025

Evalyze Launches AI Investor Matching Engine to Help Startups Fundraise Faster

Indeterminate GlobeNewswire
Cycurion, Inc. Announces Closing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
December 5, 2025

Cycurion, Inc. Announces Closing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Indeterminate GlobeNewswire
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
December 5, 2025

KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration
December 5, 2025

1910 Publishes CANDID-CNS™, an AI Model That Unlocks Beyond Rule of 5 Chemical Space and Stereochemistry to Predict Blood–Brain Barrier Penetration

Indeterminate GlobeNewswire
Apeiron Therapeutics Presents First-in-Human Data from Phase 1 Clinical Trial of GTA182 in MTAP-Deleted Advanced Non-Small Cell Lung Cancer at the ESMO Asia Congress 2025
December 5, 2025

Apeiron Therapeutics Presents First-in-Human Data from Phase 1 Clinical Trial of GTA182 in MTAP-Deleted Advanced Non-Small Cell Lung Cancer at the ESMO Asia Congress 2025

Indeterminate GlobeNewswire
M365Con.net Announces Deep Dive Microsoft Convention — Featuring New Sponsor xSP
December 5, 2025

M365Con.net Announces Deep Dive Microsoft Convention — Featuring New Sponsor xSP

Indeterminate GlobeNewswire
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
December 5, 2025

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions